Biotech Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring December 31, 2025
Biotech CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596 December 29, 2025
Biotech Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study December 28, 2025
Biotech From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream December 27, 2025
Biotech ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly December 26, 2025
Biotech Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy December 25, 2025
Biotech Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach December 23, 2025